Endocrine disturbances related to the use of lithium;Distúrbios endocrinológicos relacionados ao uso de lítio

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 56, Issue 3, 2012, Pages 153-158

  Giusti, Cecília F ^a   Amorim, Soraya R ^a   Guerra, Ricardo A ^a   Portes, Evandro S ^a  

^a Hospital do Servidor   (Brazil)

Author keywords

Diabetes insipidus; Goiter; Hypercalcemia; Lithium

Indexed keywords

LITHIUM DERIVATIVE;

CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENDOCRINE DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; MENTAL DISEASE; METABOLISM; NEPHROGENIC DIABETES INSIPIDUS; PARATHYROID GLAND; REVIEW; THYROID GLAND;

BLOOD GLUCOSE; DIABETES INSIPIDUS, NEPHROGENIC; ENDOCRINE SYSTEM DISEASES; HUMANS; LITHIUM COMPOUNDS; MENTAL DISORDERS; PARATHYROID GLANDS; THYROID GLAND;

EID: 84862679934     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302012000300001     Document Type: Review

References (58)

1. Baldessarini RJ, Tarazi FI. Tratamento farmacológico da psicose e da mania. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman e Gilman: As bases farmacológicas da terapêutica. 11. ed. Rio de Janeiro: MacGraw-Hill. 2006; p. 411-46.
2. Freeman MP, Freeman SA. Lithium: clinical considerations in internal medicine. Am J Med. 2006;119:478-81.
3. Collins N, Barnes TR, Shingleton-Smith A, Gerret D, Paton C. Standards of lithium monitoring in mental health trusts in the UK. BMC Psychiatry. 2010;10:80.
4. Simhandl C, Mersch J. [Lithium and bipolar disorder-a renaissance?]. Neuropsychiatr. 2007;21(2):121-30.
5. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function. J Psychiatry Neurosci. 1999;24(3):227-33.
6. Chiu CT, Chuang DM. Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther. 2010;128(2):281-304.
7. Jope RS. Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry. 1999;4(2):117-28.
8. Thomsen K, Shirley DG. A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol Dial Transplant. 2006;21(4):869-80.
9. Chan HH, Wing Y, Su R, Van Krevel C, Lee S. A control study of the cutaneous side effects of chronic lithium therapy. J Affect Disord. 2000;57:107-13.
10. Kayrak M, Ari H, Duman C, Gul EE, Ak A, Atalay H. Lithium intoxication causing STsegment elevation and wandering atrial rhythms in an elderly patient. Cardiol J. 2010;17(4):404-7.
11. Hundley JC, Woodrum DT, Saunders BD, Doherty GM, Gauger PG. Revisiting lithium associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery. 2005;138(6):1027-31.
12. Birnbaum J, Klandorf H, Giuliano A, Van Herle A. Lithium stimulates the release of human parathyroid hormone in vitro. J Clin Endocrinol Metab. 1987;66:1187-91.
13. Mallette LE, Khouri K, Zengotita H, Hollis BW, Malini S. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab. 1988;68:654-60.
14. Haden ST, Stoll AL, McCormick S, Scott J, Fuleihan GE. Alterations in parathyroid dynamics in lithium-treated subjects. J Clin Endocrinol Metab. 1997;82:2844-8.
15. Mak TW, Shek CC, Chow CC, Wing YK, Lee S. Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab. 1998;83:3857-9.
16. Szalat A, Mazeh H, Freund HR. Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol. 2009;160(2):317-23.
17. Sloand JA, Shelly MA. Normalization of llithium-induced hypercalcemia and hyperparathyroidism with cinecalcet hydrochloride. Am J Kidney Dis. 2006;489(5):832-7.
18. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. Lithium toxicity profile: a systematic review and meta--analysis. Lancet. 2012;379:721-8.
19. Talwar N, Mohan S, Ravi B, Andley M, Kumar A. Lithium--induced enlargement of a lingual thyroid. Singapore Med J. 2008;49(3):254-5.
20. Bauer M, Blumentritt H, Finke R, Schlattman P, Adli M, Baethge C, et al. Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders. J Affect Disord. 2007;104(1-3):45-51.
21. Mori M, Tajima K, Oda Y, Matsui I, Mashita K, Tarui S. Inhibitory effect of lithium on the release of thyroid hormones from thyrotropin-stimulated mouse thyroids in a perifusion system. Endocrinology. 1989;124:1365-9.
22. Urabe M, Hershman J, Pang XP, Murakami S, Sugawara M. Effect of lithium on function and growth of thyroid cells in vitro. Endocrinology. 1991;129:807-14.
23. Rao AS, Kremenevskaja N, Resch J, Brabant G. Lithium stimulates proliferation in cultured thyrocytes by activating Wnt/B-catenin signaling. Eur J Endocrinol. 2005;153:929-38.
24. Esposito S, Prange AJ Jr, Golden RN. The thyroid axis and mood disorders: overview and future prospects. Psychopharmacol Bull. 1997;33:205-17.
25. Henry C. Lithium side effects and predictors of hypothyroidism in patients with bipolar disorder: sex differences. J Psych Neuroscience. 2002;27:104-7.
26. Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health. 2006;2:23.
27. Bocchetta A, Cocco F, Velluzzi F, Del Zompo M, Mariotti S, Loviselli A. Fifteen-year follow-up of thyroid function in lithium patients. J Endocrinol Invest. 2007;30(5):363-6.
28. Loviselli A, Bocchetta A, Mossa P, Velluzi F, Bernardi F, Del Zompo M, et al. Value of thyroid echography in the long term follow-up of Lithium Treated Patients. Neuropsychobiol. 1997;36:37-41.
29. Baethge C, Blumentritt H, Berhöfer A, Bschor T, Glenn T, Adli M, et al. Finke R. Long-term lithium treatment and thyroid antibodies: a controlled study. J Psychiatry Neurosci. 2005;30:423-7.
30. Cooper DS, Greenspan FS, Ladenson PW. Thyroid gland. In: Gardner DG, Shoback D, eds. Greenspan's Basic & Clinical Endocrinology. 8th edition. New York: Lange/McGraw-Hill; 2007. p. 232.
31. Germain DLS. Regulatory effect of lithium on thyroxine metabolism in murine neural and anterior pituitary tissue. Endocrinology. 1986;120:1430-8.
32. Livingstone C, Rampes H. Lithium: a review of its adverse metabolic effects. J Psychopharmacol. 2006;20(3):347-55.
33. Fagiolini A, Kupfer DJ, Scott J, Swartz HA, Cook D, Novick DM, et al. Hypothyroidism in patients with bipolar disorder treated primarily with lithium. Epidemiol Psichiatr Soc. 2006;15(2):123-7.
34. Larsen PR, Davies TF, Schlumberger MJ, Hay ID. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th Edition. Philadelphia: WB Saunders Company. 2008;299-332.
35. Tsuchiya Y, Saji M, Isozaki O, Arai M, Tsushima T, Shizume K. Effect of lithium on deoxyribonucleic acid synthesis and iodine uptake in porcine thyroid cells in culture. Endocrinology. 1990;126:460-5.
36. Ng YW, Tiu SC, Choi KL, Chan FK, Choi CH, Kong PS, et al. Use of lithium in the treatment of thyrotoxicosis. Hong Kong Med J. 2006;12(4):254-9.
37. Bogazzi F, Bartalena L, Brogioni S, Scarcella G, Burelli A, Campomoro A, et al. Comparison of radioiodine with radioiodine plus lithium in the treatment of graves hyperthyroidism. J Clin Endocrinol Metab. 1999;84:499-503.
38. Pearce EM, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348:2646-55.
39. Nagamine M, Yoshino A, Ishii M, Ogawa T, Kurauchi S, Yoshida T, et al. Lithium-induced Hashimoto's encephalopathy: a case report. Bipolar Disord. 2008;10(7):846-8.
40. Robinson AG. Posterior pituitary. In: Gardner DG, Shoback D, eds. Greenspan's Basic & Clinical Endocrinology. 8th edition. Lange McGraw-Hill; 2007. p. 164.
41. Naves LA, Vilar L, Costa ACF, Domingues L, Casulari LA. Disturbances in the secretion and action of antidiuretic hormone. Arq Bras Endocrinol Metab. 2003;47:347-57.
42. Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PMT. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenyl cyclase activity. J Am Soc Nephrol. 2006;17:1063-72.
43. Jackson BA, Edwards RM, Dousa TP. Lithium-induced polyuria: effect of lithium on adenylate cyclase and adenosine 3́5́-monophosphate phosphodiesterase in medullary ascending limb of Henle's loop and in medullary collecting tubules. Endocrinology. 1980;107:1693-8.
44. Grandjean EM, Aubry JM. Lithium: update human knowledge using an evidence-based approach: part III: Clinical Safety. CNS Drugs. 2009;23:397-418.
45. Nielsen J, Kwon TH, Frokiaer J, Knepper MA, Nielsen S. Lithium--induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD. Am J Physiol Renal Physiol. 2006;290(5):F1222-33.
46. Le Roy V, Delmas Y, Verdoux H. Chronic renal complications induced by lithium. Encephale. 2009;35(6):605-10.
47. Reeves WB, Bichet DG, TE Andreolli. The posterior pituitary and water metabolism. In: Wilson JD, Fotser DW, Kronemberg HM, Larsen PR, eds. Williams Textbook of Endocrinology. 9th Edition. Philadelphia: WB Saunders Company; 2003; p. 341-8.
48. Bschor T, Adli M, Baethge C, Eichmann U, Ising M, Uhr M, et al. Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression. Neuropsychopharmacology. 2002;27:470-8.
49. Pushkarev VM, Tronko ND, Kostyuchenko NN, Mikoshi AS. Effect of o, p'-DDD and Li+ on apoptotic DNA fragmentation in conventionally normal and tumour tissues of human adrenal cortex. Ukr Biokhim Zh. 2007;79(2):44-9.
50. Kappes A, Vaccaro A, Kunnimalaiyaan M, Chen H. Lithium ions: a novel treatment for pheochromocytomas and paragangliomas. Surgery. 2007;141(2):161-5.
51. Anderson JH Jr, Blackard WG. Effect of lithium on pancreatic islet insulin release. Endocrinology. 1978;102:291-5.
52. Shah JH, Pishdad G. The effect of lithium on glucose and tolbutamide-induced insulin release and glucose tolerance in the intact rat. Endocrinology. 1980;107:1300-4.
53. Hermida OG, Fontela T, Ghiglione M, Uttenthal LO. Effect of lithium on plasma glucose, insulin and glucagon in normal and streptozotocin-diabetic rats: role of glucagon in the hyperglycaemic response. Br J Pharmacol. 1994;111:861-5.
54. Tabata I, Schluter J, Gulve EA, Holloszy OJ. Lithium Increases susceptibility of muscle glucose transport to stimulation by various agents. Diabetes. 1994;43(7):903-7.
55. Macko AR, Benez AN, Teachey MK, Henriksen EJ. Roles of insulin signaling and p38 MAPK activation by lithium in the transport of glucose in insulin-resistant rats skeletal muscle. Arch Physiol Biochem. 2008;114:331-9.
56. Baptista T, Teneud L, Contreras Q, Sprawl T, Burquera J, Burque M, et al. Lithium and body weight gain. Pharmacopsychiatry. 1995;28(2):35-44.
57. Chen Y, Silverstone T. Lithium weight gain. Int Clin Psychopharmacol. 1990;5(3):217-25.
58. Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Weight gain ad serum leptin levels in patients on lithium treatment. Neuropsychobiology. 2002;46:67-9.